Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T20:32:34.126Z.
Calculation as of: 2026-10-06T20:32:34.126Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 444c4789ee5bc9aeb41ce43a5a9ac385aa2bf00f4834dff778c1621e598ef681
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2017-11-29.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
28.20x
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Oramed Pharmaceuticals Inc.
Market Cap
$179.26M
EV/FCF Ratio
N/A
TTM Avg
28.20x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$180.47M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.76M
EV/FCF Ratio
N/A
TTM Avg
3.88x
3Y Avg
3.88x
5Y Avg
3.88x
Market Cap
$172.42M
EV/FCF Ratio
9.27x
TTM Avg
14.67x
3Y Avg
65.56x
5Y Avg
51.74x
Market Cap
$171.13M
EV/FCF Ratio
N/A
TTM Avg
277.79x
3Y Avg
277.79x
5Y Avg
277.79x
Market Cap
$169.53M
EV/FCF Ratio
N/A
TTM Avg
72.04x
3Y Avg
55.57x
5Y Avg
55.57x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. (ORMP) | $179.26M | N/A | 28.20x | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.75M | N/A | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.47M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $182.60M | N/A | N/A | N/A | N/A |
| Yarrow Bioscience Inc (YARW)vs › | $174.27M | N/A | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | N/A | 3.88x | 3.88x | 3.88x |
| Organogenesis Holdings Inc. (ORGO)vs › | $172.42M | 9.27x | 14.67x | 65.56x | 51.74x |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | N/A | 277.79x | 277.79x | 277.79x |
| Journey Medical Corporation (DERM)vs › | $169.53M | N/A | 72.04x | 55.57x | 55.57x |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.11M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2017-11-29 | 39.61x |
| 2017-11-28 | 41.16x |
| 2017-11-27 | 41.38x |
| 2017-11-24 | 41.60x |
| 2017-11-22 | 40.94x |
| 2017-11-21 | 39.35x |
| 2017-11-20 | 39.61x |
| 2017-11-17 | 39.48x |
| 2017-11-16 | 40.50x |
| 2017-11-15 | 39.79x |
| 2017-11-14 | 40.72x |
| 2017-11-13 | 40.01x |
| 2017-11-10 | 39.35x |
| 2017-11-09 | 40.76x |
| 2017-11-08 | 40.72x |
| 2017-11-07 | 41.20x |
| 2017-11-06 | 41.20x |
| 2017-11-03 | 41.60x |
| 2017-11-02 | 40.85x |
| 2017-11-01 | 41.25x |
| 2017-10-31 | 43.19x |
| 2017-10-30 | 43.28x |
| 2017-10-27 | 41.86x |
| 2017-10-26 | 42.88x |
| 2017-10-25 | 44.42x |
| 2017-10-24 | 46.32x |
| 2017-10-23 | 46.19x |
| 2017-10-20 | 46.98x |
| 2017-10-19 | 46.28x |
| 2017-10-18 | 47.16x |
| 2017-10-17 | 47.34x |
| 2017-10-16 | 46.54x |
| 2017-10-13 | 47.03x |
| 2017-10-12 | 47.51x |
| 2017-10-11 | 48.61x |
| 2017-10-10 | 46.76x |
| 2017-10-09 | 47.69x |
| 2017-10-06 | 48.35x |
| 2017-10-05 | 48.44x |
| 2017-10-04 | 43.63x |
| 2017-10-03 | 43.89x |
| 2017-10-02 | 44.16x |
| 2017-09-29 | 43.23x |
| 2017-09-28 | 44.47x |
| 2017-09-27 | 45.88x |
| 2017-09-26 | 46.28x |
| 2017-09-25 | 46.98x |
| 2017-09-22 | 46.67x |
| 2017-09-21 | 41.34x |
| 2017-09-20 | 41.42x |
| 2017-09-19 | 41.82x |
| 2017-09-18 | 41.78x |
| 2017-09-15 | 40.76x |
| 2017-09-14 | 40.23x |
| 2017-09-13 | 38.86x |
| 2017-09-12 | 38.16x |
| 2017-09-11 | 38.91x |
| 2017-09-08 | 39.17x |
| 2017-09-07 | 40.89x |
| 2017-09-06 | 40.72x |
| 2017-09-05 | 38.56x |
| 2017-09-01 | 36.44x |
| 2017-08-31 | 37.59x |
| 2017-08-30 | 35.51x |
| 2017-08-29 | 35.03x |
| 2017-08-28 | 35.20x |
| 2017-08-25 | 34.54x |
| 2017-08-24 | 35.11x |
| 2017-08-23 | 34.98x |
| 2017-08-22 | 35.42x |
| 2017-08-21 | 35.69x |
| 2017-08-18 | 35.20x |
| 2017-08-17 | 35.42x |
| 2017-08-16 | 35.60x |
| 2017-08-15 | 34.72x |
| 2017-08-14 | 34.10x |
| 2017-08-11 | 33.57x |
| 2017-08-10 | 33.84x |
| 2017-08-09 | 33.88x |
| 2017-08-08 | 33.92x |
| 2017-08-07 | 34.98x |
| 2017-08-04 | 34.89x |
| 2017-08-03 | 34.85x |
| 2017-08-02 | 35.11x |
| 2017-08-01 | 35.42x |
| 2017-07-31 | 35.03x |
| 2017-07-28 | 35.42x |
| 2017-07-27 | 35.60x |
| 2017-07-26 | 35.91x |
| 2017-07-25 | 37.19x |
| 2017-07-24 | 37.28x |
| 2017-07-21 | 37.19x |
| 2017-07-20 | 37.28x |
| 2017-07-19 | 37.23x |
| 2017-07-18 | 37.06x |
| 2017-07-17 | 35.91x |
| 2017-07-14 | 36.48x |
| 2017-07-13 | 35.86x |
| 2017-07-12 | 36.26x |
| 2017-07-11 | 36.92x |
| 2017-07-10 | 36.00x |
| 2017-07-07 | 35.56x |
| 2017-07-06 | 33.60x |
| 2017-07-05 | 34.74x |
| 2017-07-03 | 32.00x |
| 2017-06-30 | 32.38x |
| 2017-06-29 | 31.79x |
| 2017-06-28 | 32.72x |
| 2017-06-27 | 33.05x |
| 2017-06-26 | 30.86x |
| 2017-06-23 | 30.98x |
| 2017-06-22 | 30.56x |
| 2017-06-21 | 31.28x |
| 2017-06-20 | 31.49x |
| 2017-06-19 | 31.79x |
| 2017-06-16 | 30.98x |
| 2017-06-15 | 31.03x |
| 2017-06-14 | 30.26x |
| 2017-06-13 | 31.45x |
| 2017-06-12 | 32.21x |
| 2017-06-09 | 32.38x |
| 2017-06-08 | 31.96x |
| 2017-06-07 | 34.03x |
| 2017-06-06 | 34.03x |
| 2017-06-05 | 33.48x |
| 2017-06-02 | 35.00x |
| 2017-06-01 | 35.80x |
| 2017-05-31 | 33.98x |
| 2017-05-30 | 33.77x |
| 2017-05-26 | 34.11x |
| 2017-05-25 | 33.98x |
| 2017-05-24 | 35.00x |
| 2017-05-23 | 35.80x |
| 2017-05-22 | 34.96x |
| 2017-05-19 | 35.38x |
| 2017-05-18 | 34.36x |
| 2017-05-17 | 32.89x |
| 2017-05-16 | 34.20x |
| 2017-05-15 | 34.15x |
| 2017-05-12 | 34.58x |
| 2017-05-11 | 34.20x |
| 2017-05-10 | 35.04x |
| 2017-05-09 | 32.46x |
| 2017-05-08 | 32.63x |
| 2017-05-05 | 31.62x |
| 2017-05-04 | 31.15x |
| 2017-05-03 | 31.07x |
| 2017-05-02 | 31.53x |
| 2017-05-01 | 31.70x |
| 2017-04-28 | 32.29x |
| 2017-04-27 | 33.14x |
| 2017-04-26 | 34.83x |
| 2017-04-25 | 32.00x |
| 2017-04-24 | 28.83x |
| 2017-04-21 | 27.26x |
| 2017-04-20 | 26.76x |
| 2017-04-19 | 26.29x |
| 2017-04-18 | 26.21x |
| 2017-04-17 | 26.33x |
| 2017-04-13 | 26.00x |
| 2017-04-12 | 26.12x |
| 2017-04-11 | 26.33x |
| 2017-04-10 | 26.17x |
| 2017-04-07 | 26.38x |
| 2017-04-06 | 26.33x |
| 2017-04-05 | 9.69x |
| 2017-04-04 | 9.84x |
| 2017-04-03 | 9.64x |
| 2017-03-31 | 9.40x |
| 2017-03-30 | 9.37x |
| 2017-03-29 | 9.17x |
| 2017-03-28 | 9.26x |
| 2017-03-27 | 9.18x |
| 2017-03-24 | 8.96x |
| 2017-03-23 | 9.06x |
| 2017-03-22 | 9.15x |
| 2017-03-21 | 9.03x |
| 2017-03-20 | 9.10x |
| 2017-03-17 | 9.22x |
| 2017-03-16 | 9.22x |
| 2017-03-15 | 9.33x |
| 2017-03-14 | 9.22x |
| 2017-03-13 | 9.31x |
| 2017-03-10 | 9.22x |
| 2017-03-09 | 9.20x |
| 2017-03-08 | 9.23x |
| 2017-03-07 | 9.26x |
| 2017-03-06 | 9.34x |
| 2017-03-03 | 9.34x |
| 2017-03-02 | 9.51x |
| 2017-03-01 | 9.36x |
| 2017-02-28 | 9.25x |
| 2017-02-27 | 9.33x |
| 2017-02-24 | 9.36x |
| 2017-02-23 | 9.45x |
| 2017-02-22 | 9.66x |
| 2017-02-21 | 9.80x |
| 2017-02-17 | 9.77x |
| 2017-02-16 | 9.81x |
| 2017-02-15 | 9.89x |
| 2017-02-14 | 9.86x |
| 2017-02-13 | 9.69x |
| 2017-02-10 | 9.70x |
| 2017-02-09 | 9.53x |
| 2017-02-08 | 9.80x |
| 2017-02-07 | 9.75x |
| 2017-02-06 | 9.45x |
| 2017-02-03 | 9.39x |
| 2017-02-02 | 9.39x |
| 2017-02-01 | 9.61x |
| 2017-01-31 | 10.03x |
| 2017-01-30 | 9.95x |
| 2017-01-27 | 10.19x |
| 2017-01-26 | 9.94x |
| 2017-01-25 | 9.70x |
| 2017-01-24 | 9.67x |
| 2017-01-23 | 9.73x |
| 2017-01-20 | 9.51x |
| 2017-01-19 | 9.40x |
| 2017-01-18 | 9.62x |
| 2017-01-17 | 9.56x |
| 2017-01-13 | 9.70x |
| 2017-01-12 | 9.72x |
| 2017-01-11 | 17.75x |
| 2017-01-10 | 17.24x |
| 2017-01-09 | 16.75x |
| 2017-01-06 | 16.87x |
| 2017-01-05 | 17.72x |
| 2017-01-04 | 17.52x |
| 2017-01-03 | 17.29x |
| 2016-12-30 | 16.55x |
| 2016-12-29 | 16.98x |
| 2016-12-28 | 17.35x |
| 2016-12-27 | 17.75x |
| 2016-12-23 | 16.33x |
| 2016-12-22 | 16.07x |
| 2016-12-21 | 16.27x |
| 2016-12-20 | 16.50x |
| 2016-12-19 | 16.36x |
| 2016-12-16 | 16.16x |
| 2016-12-15 | 16.19x |
| 2016-12-14 | 16.61x |
| 2016-12-13 | 17.12x |
| 2016-12-12 | 16.70x |
| 2016-12-09 | 17.38x |
| 2016-12-08 | 16.95x |
| 2016-12-07 | 17.35x |
| 2016-12-06 | 18.29x |
| 2016-12-05 | 17.32x |
| 2016-12-02 | 17.18x |
| 2016-12-01 | 16.50x |
| 2016-11-30 | 16.61x |
| 2016-11-29 | 17.15x |
| 2016-11-28 | 16.53x |
